
“In April, an expert advisory panel for the FDA voted unanimously to recommend Epidiolex’s approval and determined that ‘CBD has a negligible abuse potential.’ The DEA did not immediately respond to Ars’ request for comment. But GW said it expects that the DEA will reschedule CBD within 90 days.”
Related posts:
The Communist Romania Exit Tax
Debt: Still Cheap, and Getting Looser
NSA slides: Steve Jobs Is 'Big Brother' And Smartphone Users Are 'Zombies'
Death From Above: Navy Drone Logo Features Grim Reaper
Oregon: Jesus Malverde Medallion Did Not Justify Traffic Stop
Prison State Chronicles
Groklaw Shuts Down Over U.S. Internet Surveillance
Former S.C. Republican official: ‘C*cksucker’ anti-war vet should have ‘come home in a body bag’
The “I Thought Bonds Were Safe” Fallacy…
Documents reveal U.S. sells arms to Bahrain’s anti-democracy government crackdown
A Massage Parlour Owner Explains How Bitcoin Will Help Attract Clients
Pay me in gold: Romania's new term as it gets more of Rosia Montana
CIA Allowed To Sustain Cover-Up of Bay Of Pigs History; Reclassification Denied
Introducing Blackphone: The Ultimate NSA-Proof Smartphone
Natural Gas Opportunities for MLP Investors